NEW YORK--(BUSINESS WIRE)-- Levi & Korsinsky announces it has commenced an investigation of INC Research Holdings, Inc. (NASDAQ:INCR) (“INC” or the “Company”) concerning possible violations of federal securities laws.
On August 1, 2017, INC and inVentiv Health, Inc. ("inVentiv") announced the completion of a merger between the two companies. On November 9, 2017, INC reported its first financial results after combining with inVentiv. The Company's combined results were negatively impacted by merger-related expenses, an impairment charge, and increased amortization expenses.
On this news, INC Research's share price fell $16.35, or 28.43%, to close at $41.15 on November 9, 2017. To obtain additional information, go to:
or contact Joseph E. Levi, Esq. either via email at email@example.com or by telephone at (212) 363-7500, toll-free: (877) 363-5972.
Levi & Korsinsky is a national firm with offices in New York, California, Connecticut and Washington D.C. The firm’s attorneys have extensive expertise in prosecuting securities litigation involving financial fraud, representing investors throughout the nation in securities and shareholder lawsuits. Attorney advertising. Prior results do not guarantee similar outcomes.
Levi & Korsinsky, LLP
Eduard Korsinsky, Esq.
30 Broad Street - 24th Floor
New York, NY 10004
Tel: (212) 363-7500
Toll Free: (877) 363-5972
Fax: (212) 363-7171
View source version on businesswire.com: http://www.businesswire.com/news/home/20171204005978/en/
Levi & Korsinsky
Joseph E. Levi, Esq.
(212) 363-7500, toll-free: (877) 363-5972
Source: Levi & Korsinsky